Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 28;23(1):1421.
doi: 10.4102/sajhivmed.v23i1.1421. eCollection 2022.

HIV viral load suppression before and after COVID-19 in Kinshasa and Haut Katanga, Democratic Republic of the Congo

Gulzar H Shah  1 , Gina D Etheredge  2 , Stacy W Smallwood  3 , Lievain Maluantesa  4 , Kristie C Waterfield  1 , Osaremhen Ikhile  1 , John Ditekemena  4 , Elodie Engetele  2 , Elizabeth Ayangunna  1 , Astrid Mulenga  4 , Bernard Bossiky  5
Affiliations

HIV viral load suppression before and after COVID-19 in Kinshasa and Haut Katanga, Democratic Republic of the Congo

Gulzar H Shah et al. South Afr J HIV Med. .

Abstract

Background: The coronavirus disease 2019 (COVID-19) pandemic resulted in unique programmatic opportunities to test hypotheses related to the initiation of antiretroviral treatment (ART) and viral load (VL) suppression during a global health crisis, which would not otherwise have been possible.

Objectives: To generate practice-relevant evidence on the impact of initiating ART pre-COVID-19 versus during the COVID-19 pandemic on HIV VL.

Method: Logistic regression was performed on data covering 6596 persons with HIV whose VL data were available, out of 36 585 persons who were initiated on ART between 01 April 2019 and 30 March 2021.

Results: After controlling for covariates such as age, gender, duration on ART, tuberculosis status at the time of the last visit, and rural vs urban status, the odds of having a VL < 1000 copies/mL were significantly higher for clients who started ART during the COVID-19 pandemic than the year before COVID-19 (adjusted odds ratio [AOR]: 2.50; confidence interval [CI]: 1.55-4.01; P < 0.001). Odds of having a VL < 1000 copies/mL were also significantly higher among female participants than male (AOR: 1.23; CI: 1.02-1.48), among patients attending rural clinics compared to those attending urban clinics (AOR: 1.83; CI: 1.47-2.28), and in clients who were 15 years or older at the time of their last visit (AOR: 1.50; CI: 1.07-2.11).

Conclusion: Viral loads did not deteriorate despite pandemic-induced changes in HIV services such as the expansion of multi-month dispensing (MMD), which may have played a protective role regardless of the general negative impacts of response to the COVID-19 crises on communities and individuals.

What this study adds: This research capitalises on the natural experiment of COVID-19-related changes in HIV services and provides new practice-relevant research evidence.

Keywords: COVID-19; Democratic Republic of Congo; HIV; PLHIV; antiretroviral treatment; viral load.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.

Similar articles

See all similar articles

Cited by

References

    1. Nyasulu JCY, Maposa I, Sikhakhane BP, Pandya H. Access to HIV services and viral load suppression among children during the 90-90-90 strategy implementation in South Africa: A time series analysis. S Afr J HIV Med. 2021;22(1):e1–e8. 10.4102/sajhivmed.v22i1.1187 - DOI - PMC - PubMed
    1. Balachandra S, Rogers JH, Ruangtragool L, et al. . Concurrent advanced HIV disease and viral load suppression in a high-burden setting: Findings from the 2015–6 ZIMPHIA survey. PLoS One. 2020;15(6):1–12. 10.1371/journal.pone.0230205 - DOI - PMC - PubMed
    1. Lecher SL, Naluguza M, Mwangi C, et al. . Notes from the field: Impact of the COVID-19 response on scale-up of HIV viral load testing – PEPFAR-supported countries, January–June 2020. MMWR Morb Mortal Wkly Rep. 2021;70(21):794–795. 10.15585/mmwr.mm7021a3 - DOI - PMC - PubMed
    1. World Health Organization . Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization Press; 2015. - PubMed
    1. Golin R, Godfrey C, Firth J, et al. . PEPFAR’s response to the convergence of the HIV and COVID-19 pandemics in sub-Saharan Africa. J Int AIDS Soc. 2020;23(8):e25587. 10.1002/jia2.25587 - DOI - PMC - PubMed

LinkOut - more resources